Trulieve Announces Uplist to NYSE
Trulieve Cannabis Corp., a leading U.S. medical cannabis company, announced that its subordinate voting shares will begin trading on the New York Stock Exchange under ticker 'TRLV' starting June 10, 2026. The uplisting follows recent regulatory changes allowing DEA registration for state-licensed medical marijuana businesses and is expected to expand Trulieve's shareholder base and liquidity.

Topics: cannabis medical marijuana nyse listing